Showing results (311-320 of 361) with videos related to

Sort By:
Pageof 37
International Journal of Cancer|January 29, 2026
Cumulative exposure to tacrolimus is associated with increased risk of malignancy for solid organ transplant recipientsSergio A Acuna, Xun Zhao, Maggie Jones-Carr, et al.
Canadian Journal of Kidney Health and Disease|August 4, 2025
Frequency, Management, and Outcomes of Outpatient Hyperkalemia: A Population-Based Cohort StudyMichael Chiu, Nivethika Jeyakumar, Graham Smith, et al.
Trials|July 23, 2013
Involving service users in trials: developing a standard operating procedureBridie Angela Evans, Emma Bedson, Philip Bell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2018
HER3-Mediated Resistance to Hsp90 Inhibition Detected in Breast Cancer Xenografts by Affibody-Based PET ImagingCarlos D Martins, Chiara Da Pieve, Thomas A Burley, et al.
Open Forum Infectious Diseases|March 30, 2022
Long-Term Efficacy, Safety, and Durability of Cabotegravir and Rilpivirine as 2-Drug Oral Maintenance Therapy After 6 Years of StudyKenneth C Sutton, Jerome De Vente, Roger Leblanc, et al.
Chemical Communications (Cambridge, England)|December 14, 2011
Copper-free click--a promising tool for pre-targeted PET imagingHelen L Evans, Rozanna L Slade, Laurence Carroll, et al.
Plos One|July 9, 2016
Prevalence of Sexually Transmitted Viral and Bacterial Infections in HIV-Positive and HIV-Negative Men Who Have Sex with Men in TorontoRobert S Remis, Juan Liu, Mona R Loutfy, et al.
AIDS Research and Human Retroviruses|October 6, 2020
Cardiovascular Events in an Inner-City HIV Clinic and Relationship to Abacavir Versus Tenofovir Disoproxil Fumarate-Containing Antiretroviral RegimensBrenda Varriano, Frederic Crouzat, Ina Sandler, et al.
Clinical Chemistry|October 6, 2010
A bioluminescent microbial biosensor for in vitro pretreatment assessment of cytarabine efficacy in leukemiaHabib M Alloush, Elizabeth Anderson, Ashley D Martin, et al.
International Journal of STD & AIDS|May 2, 2019
Assessment of antiretroviral third agent virologic durability after initiation of first antiretroviral regimenBrenda Varriano, Ina Sandler, Mona Loutfy, et al.
Pageof 37